How Much Can Companies Make From Coronavirus Vaccines?

Brian Orelli, PhD, The Motley Fool
·2-min read

In this video from Motley Fool Live recorded on Nov. 23, Corinne Cardina, bureau chief of healthcare and cannabis, and Brian Orelli, Fool.com contributor, discuss the prices from the initial government contracts and a website from Duke University that tracks the contracts. Corinne Cardina: Both Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are charging the U.S. about $20 per dose. Moderna's CEO has said the company will price it between $25 to $37 per dose depending on the amount ordered by other governments.